PMID- 25452166 OWN - NLM STAT- MEDLINE DCOM- 20151029 LR - 20181113 IS - 1098-1136 (Electronic) IS - 0894-1491 (Print) IS - 0894-1491 (Linking) VI - 63 IP - 4 DP - 2015 Apr TI - Macrophages in spinal cord injury: phenotypic and functional change from exposure to myelin debris. PG - 635-51 LID - 10.1002/glia.22774 [doi] AB - Macrophage activation and persistent inflammation contribute to the pathological process of spinal cord injury (SCI). It was reported that M2 macrophages were induced at 3-7 days after SCI but M2 markers were reduced or eliminated after 1 week. By contrast, M1 macrophage response is rapidly induced and then maintained at injured spinal cord. However, factors that modulate macrophage phenotype and function are poorly understood. We developed a model to distinguish bone-marrow derived macrophages (BMDMs) from residential microglia and explored how BMDMs change their phenotype and functions in response to the lesion-related factors in injured spinal cord. Infiltrating BMDMs expressing higher Mac-2 and lower CX3CR1 migrate to the epicenter of injury, while microglia expressing lower Mac-2 but higher CX3CR1 distribute to the edges of lesion. Myelin debris at the lesion site switches BMDMs from M2 phenotype towards M1-like phenotype. Myelin debris activates ATP-binding cassette transporter A1 (ABCA1) for cholesterol efflux in response to myelin debris loading in vitro. However, this homeostatic mechanism in injured site is overwhelmed, leading to the development of foamy macrophages and lipid plaque in the lesion site. The persistence of these cells indicates a pro-inflammatory environment, associated with enhanced neurotoxicity and impaired wound healing. These foamy macrophages have poor capacity to phagocytose apoptotic neutrophils resulting in uningested neutrophils releasing their toxic contents and further tissue damage. In conclusion, these data demonstrate for the first time that myelin debris generated in injured spinal cord modulates macrophage activation. Lipid accumulation following macrophage phenotype switch contributes to SCI pathology. CI - (c) 2014 Wiley Periodicals, Inc. FAU - Wang, Xi AU - Wang X AD - W. M. Keck Center for Collaborative Neuroscience, Rutgers, The State University of New Jersey, New Jersey; Institute of Neurosciences, the Fourth Military Medical University, Xian, China. FAU - Cao, Kai AU - Cao K FAU - Sun, Xin AU - Sun X FAU - Chen, Yongxiong AU - Chen Y FAU - Duan, Zhaoxia AU - Duan Z FAU - Sun, Li AU - Sun L FAU - Guo, Lei AU - Guo L FAU - Bai, Paul AU - Bai P FAU - Sun, Dongming AU - Sun D FAU - Fan, Jianqing AU - Fan J FAU - He, Xijing AU - He X FAU - Young, Wise AU - Young W FAU - Ren, Yi AU - Ren Y LA - eng GR - R01 GM100474/GM/NIGMS NIH HHS/United States GR - R01GM100474-03/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20141128 PL - United States TA - Glia JT - Glia JID - 8806785 RN - 0 (ABCA1 protein, mouse) RN - 0 (ATP Binding Cassette Transporter 1) RN - 0 (Biomarkers) RN - 0 (CX3C Chemokine Receptor 1) RN - 0 (Cx3cr1 protein, mouse) RN - 0 (Galectin 3) RN - 0 (Macrophage-1 Antigen) RN - 0 (Receptors, Chemokine) SB - IM MH - ATP Binding Cassette Transporter 1/metabolism MH - Animals MH - Biomarkers/metabolism MH - CX3C Chemokine Receptor 1 MH - Disease Models, Animal MH - Galectin 3/metabolism MH - Inflammation/metabolism MH - Macrophage Activation/*immunology MH - Macrophage-1 Antigen/metabolism MH - Macrophages/cytology/immunology/*metabolism MH - Mice MH - Microglia/cytology/*immunology MH - Myelin Sheath/immunology/*metabolism MH - Phagocytosis/immunology MH - Receptors, Chemokine/metabolism MH - Signal Transduction/*immunology MH - Spinal Cord Injuries/*immunology/metabolism PMC - PMC4331228 MID - NIHMS643077 OTO - NOTNLM OT - foamy cells OT - macrophages OT - myelin debris OT - spinal cord injury COIS- Conflict of Interest The authors declare no competing financial interests. EDAT- 2014/12/03 06:00 MHDA- 2015/10/30 06:00 PMCR- 2016/04/01 CRDT- 2014/12/03 06:00 PHST- 2014/04/11 00:00 [received] PHST- 2014/11/05 00:00 [revised] PHST- 2014/11/12 00:00 [accepted] PHST- 2014/12/03 06:00 [entrez] PHST- 2014/12/03 06:00 [pubmed] PHST- 2015/10/30 06:00 [medline] PHST- 2016/04/01 00:00 [pmc-release] AID - 10.1002/glia.22774 [doi] PST - ppublish SO - Glia. 2015 Apr;63(4):635-51. doi: 10.1002/glia.22774. Epub 2014 Nov 28.